Endovia touts federal Schedule III support; CannEpil FDA submission due next week

SPLASH BEVERAGE GROUP, INC.

Federal government voiced support during DEA hearings for moving marijuana to Schedule III; Endovia calls it a policy shift.
Endovia expects to submit CannEpil® pre-submission conference request to FDA in the coming week.
Company is evaluating additional cannabinoid formulations/IP for licensing, acquisition, or collaboration.
Working with capital partners to finalize expanded financing for development and potential deals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.